NCT00093158View on ClinicalTrials.gov

Comparison of Angiomax Versus Heparin in Acute Coronary Syndromes (ACS)

PHASE3CompletedINTERVENTIONAL
Enrollment

13,800

Participants

Timeline

Start Date

August 31, 2003

Study Completion Date

January 31, 2007

Conditions
Unstable AnginaMyocardial InfarctionAcute Disease
Interventions
DRUG

Angiomax (bivalirudin) anticoagulant

Trial Locations (1)

10022

Cardiovascular Research Foundation, New York

Sponsors
All Listed Sponsors
lead

The Medicines Company

INDUSTRY